SCHEMBL97196

SCHEMBL97196

CCn1c(=O)c2ccccc2c2cc(C=O)ccc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 5/20 0.61
PGR P06401 6/20 0.55
KDM4E B2RXH2 3/20 0.51
POLB P06746 1/20 0.51
PKM P14618 1/20 0.51
HTT P42858 1/20 0.51
RORA P35398 6/20 0.50
RORC P51449 6/20 0.50
RORB Q92753 6/20 0.50
SRC P12931 2/20 0.49
ALDH1A1 P00352 3/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
NPC1 O15118 1/20 0.47
USP2 O75604 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29507657 0.86 PTGER4 (0.70) PTGER4KDM4EPOLBPKMHTT
SCHEMBL416844 0.86 PTGER4 (0.70) PTGER4KDM4EPOLBPKMHTT
SCHEMBL14141638 0.86 RORA (0.70) PTGER4PGRRORARORCRORB
SCHEMBL96124 0.86 SRC (0.51) PTGER4PGRKDM4EPOLBRORA
SCHEMBL29794143 0.84 PTGER4 (0.81) PTGER4KDM4EPOLBPKMHTT
SCHEMBL4832600 0.84 PTGER4 (0.81) PTGER4KDM4EPOLBPKMHTT
SCHEMBL31021117 0.79 PTGER4 (0.60) PTGER4KDM4EPOLBPKMHTT
Butanone SCHEMBL27600092 0.79 KDM4E (0.61) PTGER4KDM4EPOLBPKMHTT
SCHEMBL11720741 0.79 PGR (0.69) PGRKDM4EHTTRORARORC
SCHEMBL20227728 0.79 PGR (0.58) PGRKDM4ERORARORCRORB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
CN-101068810-B Carbostyril compound OTSUKA PHARMA CO LTD 2011-02-09 CN disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
CN-101068810-A Carbostyril compound OTSUKA PHARMA CO LTD (JP) 2007-11-07 CN disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 PTGER4 368/4885PGR 3206/4885KDM4E 3919/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 PTGER4 368/4885PGR 3206/4885KDM4E 3919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.